Castellan Real Estate: How Much of Bond Protection Is Common Equity, and How Much Is Sponsor-Routed Capital

What This Follow-up Is Isolating

The main article argued that the visible conservatism in Castellan's loan book does not fully explain the bondholder protection story. This follow-up isolates the capital layer. As of December 31, 2025, the company reports net assets of $109.8 million, but the capital used for bond covenant purposes stands at $149.0 million. The entire gap, $39.2 million, is a subordinated shareholder loan.

That is not a cosmetic distinction. Net assets are the ordinary loss-absorbing layer. A subordinated shareholder loan is already a claim held by the sponsor, even if it carries no interest, has no maturity date, and is subordinated to the rest of the debt stack. So the right question here is not only whether there is a cushion, but how much of that cushion is common equity and how much is capital routed through the controlling shareholder.

The point becomes sharper because of the dividend approved on March 25, 2026 for $8.495 million. The sole shareholder said it intends to use the distribution proceeds to increase the same subordinated shareholder loan. In other words, the same money can leave the company as a dividend and come back as junior sponsor capital, while the covenant number stays tidier than the common-equity layer.

What the Indentures Count, and What the Balance Sheet Counts

Castellan reports under an investment-company format, so the core line in the consolidated statements is net assets rather than plain-share equity language. In section 2.1 of the directors' report, the company explicitly shows two separate figures: net assets of $109.804 million and capital for bond covenant calculations of $149.001 million. The difference is exactly the year-end subordinated shareholder loan balance of $39.197 million.

The reason is also explicit in the bond definitions. For covenant purposes, "equity" includes subordinated shareholder loans, principal only. Put differently, the indentures treat part of sponsor capital as a protective equity layer. That does provide real support to bondholders, but it is not the same thing as ordinary common equity left inside the company with no sponsor claim attached to it.

The number is material. The subordinated shareholder loan represents about 26% of covenant capital and about 36% of reported net assets. So anyone reading the $149 million figure as fully hard equity is missing the composition. This is not a near-breach story. At December 31, 2025 the company was in compliance, with net financial debt to net CAP of about 68% and the Series B loan-to-collateral ratio at about 72%. The issue is capital quality, not the absence of a cushion.

That distinction matters even more because the subordinated shareholder loan was not built mainly through profits retained inside the public entity. A large part of it was created at the public-entity starting point itself, when $50 million of the transferred rights were reclassified from equity into a subordinated shareholder loan. So from day one, a meaningful part of the covenant cushion was deliberately structured as junior sponsor debt rather than plain common equity.

How the Junior Shareholder Loan Moved During the Year

Note 6 is the center of gravity here because it shows that this layer did not sit still. During 2025 it moved in several directions: a $50.0 million reclassification from equity into a subordinated shareholder loan, $2.110 million of in-kind distributions against equity, an additional $4.605 million of subordinated shareholder-loan funding, $8.791 million of partial repayments, and $8.727 million classified as dividend paid. The balance ended the year at $39.197 million.

The important point is not only the end balance but the character of the movement. The protective layer counted by the indentures is not a fixed block of fresh capital permanently parked under the bonds. It already changed shape during the year through reclassification, additions, repayments, and dividend-related movements. For bondholders, that makes it more accurate to view this as sponsor support capital rather than pure common equity.

There is another important nuance. Because the company was formed through a transfer of existing rights into a new listed vehicle, the first $50 million of the subordinated shareholder loan did not come from a later fresh-cash infusion specifically made to strengthen bondholder protection. It was created out of the transfer itself. So when reading the quality of protection, it is wrong to treat the entire $149 million covenant-capital figure as if it were all common equity built inside the public company.

The Dividend Loop, and Why It Changes Protection Quality

In Part A, section 4 of the annual report, the company lists two relevant distributions. One was approved on November 24, 2025 for $2.100 million. The second was approved on March 25, 2026 for $8.495 million. In both cases, the shareholder said it intended to use the distribution proceeds to increase the subordinated shareholder loan. The immediate report dated March 27, 2026 repeats that point and adds that the board reviewed both the statutory distribution tests and the bond-indentures' distribution limits before approving the dividend.

This is the core of the follow-up. The dividend here is not just cash leaving the company, and it is not just a standard capital-allocation event to the sponsor. It is part of an explicitly disclosed capital circuit: money leaves as a dividend and the shareholder intends to return it through the same junior shareholder-loan instrument. That is a loop. From a covenant-reading perspective, that loop can preserve the covenant-capital number better than it preserves the common-equity layer.

For illustration, the dividend approved in March 2026 equals about 7.7% of year-end net assets and about 5.7% of covenant capital. If the amount does come back in full as a subordinated shareholder loan, the company can preserve much of the covenant cushion without rebuilding ordinary equity by the same amount. In composition terms, the shareholder-loan share inside covenant capital would rise from roughly 26% to roughly 32%, assuming everything else stayed unchanged. That is not a forecast for the next report. It is simply the mechanical direction implied by the capital path the company and the shareholder described themselves.

The management agreement adds one more relevant layer. The company says the manager is entitled to an annual fee equal to 1.5% of the company's equity plus the subordinated shareholder loan, subject to offsets from part of borrower fees. That means a switch from common equity to shareholder-loan capital does not, by itself, shrink the management-fee base. That does not make the structure problematic on its own, but it does mean the system is not built to clearly privilege common equity over capital routed through the sponsor.

What Bondholders Should Take From This

The fair reading of the structure requires two statements that sound contradictory and are both true. On one hand, the subordinated shareholder loan is real support. It carries no interest, has no maturity date, is subordinated to the rest of the liabilities, and cannot be repaid as long as the company would fail the distribution limits after such repayment. For bondholders, that is much better than ordinary sponsor debt.

On the other hand, it is still not the same thing as common equity. It is sponsor capital, not claim-free residual equity. It already changed shape during the year, and it is explicitly linked to a distribution mechanism under which money can leave as a dividend and return as a shareholder loan. So when reading the bond cushion, investors need to track two numbers separately: how much net assets the company truly retains, and how much of the cushion sits inside a shareholder-loan layer that is counted into the covenant.

The three monitoring points from here are straightforward:

• Whether net assets themselves keep growing, or whether the covenant number leans increasingly on subordinated shareholder loans.
• Whether future distributions are again approved together with notices that the proceeds will be recycled through the same junior shareholder-loan channel.
• Whether future earnings stay in the company to strengthen ordinary equity, or continue to move through a distribution-and-return loop.

Bottom line: at the end of 2025, Castellan's bond-protection layer looks adequate, but its quality is less straightforward than the headline number suggests. Covenant capital stands at $149.0 million, yet $39.2 million of that amount is a subordinated shareholder loan, and the approved distributions show that this layer already participates in a sponsor-facing capital loop. The right read is therefore not "$149 million of equity", but $109.8 million of net assets plus $39.2 million of sponsor-routed junior capital. For bondholders, that difference matters.